Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:13 PM
Ignite Modification Date:
2025-12-24 @ 1:13 PM
NCT ID:
NCT05894395
Eligibility Criteria:
Inclusion Criteria:
* Aged 18-49 (inclusive) at the time of the study screening visit
* Has received exactly two previous doses of MMR-containing vaccine at any point up to one calendar year prior to the study screening visit
* Willing to receive a booster MMR vaccination as outlined in the study protocol
* Able and willing to comply with all other study requirements (attend all study visits and provide blood, saliva, nasal wash samples at each visit as outlined)
* Sufficient language (German or English) and cognitive skills
* Provides written, informed consent to participate in the study
Exclusion Criteria:
* Acute respiratory or other infections (postpone baseline visit until resolved)
* Receipt of any other vaccination less than 4 weeks prior to the baseline visit or intention to receive another vaccination within 4 weeks following the baseline visit
* Previous hypersensitivity reaction following receipt of any MMR-containing vaccine or previous hypersensitivity reaction to any component of M-M-R-vaxPro
* Pregnancy, lactation, or intention to become pregnant during the study
* Individuals with confirmed or suspected immunosuppressive or immune-deficient state
* Known current or chronic or severe disease
* Receipt of blood or plasma transfusions, or administration of immune globulin (IG) less than 12 weeks prior to the baseline visit, or intention to receive IG within 4 weeks following the baseline visit
* Any other significant disease, disorder, or finding which could potentially result in an increased risk to the volunteer due to participation in the study
* Being enrolled in another interventional study that may interfere with the current study
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
49 Years
Study:
NCT05894395
Study Brief:
Protocol Section:
NCT05894395